Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader
Cited by 25
Related Papers
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases
|ACS Chemical Biology|2015|290
Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53
|Journal of the American Chemical Society|2023|53
Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer
|Journal of Medicinal Chemistry|2023|50
Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2
|European Journal of Medicinal Chemistry|2024|36